Instituto de Investigación Biomédica de A Coruña (INIBIC)
Research center
Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer
Salamanca, EspañaPublications in collaboration with researchers from Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer (8)
2024
-
A new BRAF inhibitor breaks resistance barriers
Trends in Cancer
2023
-
A Human Hereditary Cardiomyopathy Shares a Genetic Substrate With Bicuspid Aortic Valve
Circulation, Vol. 147, Núm. 1, pp. 47-65
-
TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1-deficient mice in bleomycin-induced experimental model of scleroderma
Arthritis Research and Therapy, Vol. 25, Núm. 1
2022
-
Inflammation in Health and Disease: New Insights and Therapeutic Avenues
International Journal of Molecular Sciences
2019
-
Discovery of an autoantibody signature for the early diagnosis of knee osteoarthritis: Data from the Osteoarthritis Initiative
Annals of the Rheumatic Diseases, Vol. 78, Núm. 12, pp. 1699-1705
2017
-
Screening and Validation of Novel Biomarkers in Osteoarticular Pathologies by Comprehensive Combination of Protein Array Technologies
Journal of Proteome Research, Vol. 16, Núm. 5, pp. 1890-1899
2014
-
Emerging Nanotechniques in Proteomics
Comprehensive Analytical Chemistry (Elsevier B.V.), pp. 137-157
2008
-
Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer
Journal of the National Cancer Institute, Vol. 100, Núm. 11, pp. 805-814